Search for Clinical Trial Results

Sponsored By

Cholangitis - 62 Studies Found

Status Study
Completed Study Name: A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cholangitis
Date: 2015-08-04
Interventions:
  • Drug: LJN452 LJN452 capsules a
Active, not recruiting Study Name: Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cirrhosis
Date: 2015-12-19
Not yet recruiting Study Name: A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Condition: Primary Biliary Cirrhosis
Date: 2017-04-10
Interventions:
  • Drug: Saroglitazar magnesium 2 mg

Completed Study Name: Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2008-12-08
Interventions:
  • Drug: Tetrathiomolybdate 120 m
Completed Study Name: Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2015-09-21
Interventions: Dietary Supplement: S-adenosyl-L-methionine Patients will be treated with S-adenosyl-L-methionine, table
Completed Study Name: High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2012-05-17
Interventions: Dietary Supplement: High protein high fiber diet A personalized high protein high fiber dietary plan wil
Completed Study Name: Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Date: 2011-04-25
Interventions:
  • Procedure: plastic endoprosthesis

Completed Study Name: Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Condition: Primary Sclerosing Cholangitis
Date: 2016-06-13
Interventions:
  • Drug: GS-9674 Tablet(s) admini
Completed Study Name: Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Date: 2012-08-22
Interventions:
  • Biological: Simtuzumab Other N
Active, not recruiting Study Name: Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Date: 2014-06-26
Interventions:
  • Drug: OCA
  • Drug: Placebo
<<< Previous | Next >>>